These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24146939)

  • 21. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
    Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
    Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
    Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
    Matsubara T; Onishi A; Yamaguchi D; Sato T
    Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.
    Plotch SJ; O'Hara B; Morin J; Palant O; LaRocque J; Bloom JD; Lang SA; DiGrandi MJ; Bradley M; Nilakantan R; Gluzman Y
    J Virol; 1999 Jan; 73(1):140-51. PubMed ID: 9847316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication.
    La Frazia S; Piacentini S; Riccio A; Rossignol JF; Santoro MG
    Antiviral Res; 2018 Sep; 157():159-168. PubMed ID: 29908209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies of development of antiviral agents directed against influenza virus replication.
    Hsieh HP; Hsu JT
    Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.
    Zhao H; To KKW; Sze KH; Yung TT; Bian M; Lam H; Yeung ML; Li C; Chu H; Yuen KY
    Nat Commun; 2020 Aug; 11(1):4252. PubMed ID: 32843628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
    Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
    Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.
    Makau JN; Watanabe K; Ishikawa T; Mizuta S; Hamada T; Kobayashi N; Nishida N
    PLoS One; 2017; 12(3):e0173582. PubMed ID: 28273150
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.
    Di Trani L; Savarino A; Campitelli L; Norelli S; Puzelli S; D'Ostilio D; Vignolo E; Donatelli I; Cassone A
    Virol J; 2007 May; 4():39. PubMed ID: 17477867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
    Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
    Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
    J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.
    Mathew S; Al Thani AA; Yassine HM
    PLoS One; 2018; 13(9):e0203148. PubMed ID: 30180218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.
    Nile SH; Kim DH; Nile A; Park GS; Gansukh E; Kai G
    Food Chem Toxicol; 2020 Jan; 135():110985. PubMed ID: 31765700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.